Search filters

Filters
Clear All

Phase

  • 18
  • 63
  • 42
  • 80
  • 13
  • 93
  • 13
  • 581
  • 934
  • 404
  • 12
  • 45
  • 881
  • 931
  • 7
  • 20
  • 918

Found 938 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years or above
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication compared to observation in patients with intermediate risk non-muscle invasive bladder cancer (NMIBC). The study aims to understand how the investigational treatment affects the condition in comparison to standard observation.Participants in the study will either receive the investigational medication or be …
18 years or above
All genders
Phase 3
Interventional
This study investigates the use of investigational medications for treating metastatic non-small cell lung cancer (mNSCLC) in patients whose tumors express PD-L1. The purpose of this study is to compare the effectiveness and safety of two treatments: one investigational medication and a standard treatment, pembrolizumab. Participants will be randomly assigned …
18 years or above
All genders
Phase 2
Interventional
This study investigates the safety and effects of an investigational medication in adults with carcinoid syndrome. The purpose of this study is to evaluate how the investigational medication works in the body and its safety for people with this syndrome.Participants will first be randomly assigned to receive either the investigational …
18 years or above
All genders
Phase 3
Interventional
The purpose of this study is to investigate the effect of adding an investigational medication to the immunotherapy drug durvalumab in patients with non-small cell lung cancer (NSCLC) who have undergone chemotherapy and surgery. The study aims to see if the combination of treatments can increase the time patients remain …
18 years or above
All genders
Phase 2
Interventional
This study investigates the safety and effectiveness of adding RP2, an investigational treatment, to the standard chemotherapy regimen, FLOT, for patients with stage II or higher, non-metastatic gastroesophageal adenocarcinoma. The purpose of this study is to determine if injecting RP2 directly into the tumors of the stomach and esophagus, combined …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effectiveness of combining hormone therapy with or without an investigational medication in treating patients with breast cancer. Hormone therapies like tamoxifen citrate and others work by lowering estrogen levels, potentially slowing or stopping cancer growth. The investigational medication being studied may also stop tumor growth by …
99 years or below
All genders
We propose an iterative approach to develop and pilot test a new mHealth behavioral intervention for AET adherence that is culturally tailored to Black breast cancer survivors. We will first use qualitative methods informed by Black breast cancer survivors to develop a blueprint of the intervention (Aim 1). We will …
99 years or below
All genders
All objectives are listed in section 3 of the protocol, but the primary objective is to evaluate the long-term safety of RAP-219 in participants with focal onset seizures. The primary endpoint is the incidence of treatment-emergent adverse events (TEAEs). The secondary objectives and their associated endpoints can be found in …
TRITON-CM
18 years - 85 years
All genders
The purpose of this study is to:Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortality and cardiovascular (CV) eventsEvaluate the efficacy of nucresiran compared to placebo on additional assessments of CV events and/or deathEvaluate the efficacy of nucresiran compared to placebo on patient-reported health status and health-related …
99 years or below
All genders
Please see the full protocol, refer to Section 2, Objectives. Please see the full protocol, Section 3.2.6 Outcomes Data. Please see the full protocol, Section 11, Statistical Considerations.
801 - 810 of 938